SlideShare ist ein Scribd-Unternehmen logo
1 von 58
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Psychotherapeutic AgentsPsychotherapeutic Agents
AntidepressantsAntidepressants
and Antipsychoticsand Antipsychotics
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
PsychotherapeuticsPsychotherapeutics
• The therapy of emotional and mentalThe therapy of emotional and mental
disordersdisorders
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
PsychotherapeuticsPsychotherapeutics
• AnxietyAnxiety
• GriefGrief
• DepressionDepression
are normal human emotionsare normal human emotions
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
PsychotherapeuticsPsychotherapeutics
• The ability to cope with these emotions canThe ability to cope with these emotions can
range from occasional depression or anxietyrange from occasional depression or anxiety
to constant emotional distress to the pointto constant emotional distress to the point
ofinterfering with the ability to carry onofinterfering with the ability to carry on
normal daily living.normal daily living.
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
PsychotherapeuticsPsychotherapeutics
• When these emotions significantly affect anWhen these emotions significantly affect an
individual’s ability to carry out normal dailyindividual’s ability to carry out normal daily
functions, treatment with a psychotherapeuticfunctions, treatment with a psychotherapeutic
drug is a possible option.drug is a possible option.
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
PsychotherapeuticsPsychotherapeutics
Three main emotional and mental disorders:Three main emotional and mental disorders:
• PsychosesPsychoses
• Affective disordersAffective disorders
• AnxietyAnxiety
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
PsychotherapeuticsPsychotherapeutics
PsychosisPsychosis
• A major emotional disorder that impairs the mentalA major emotional disorder that impairs the mental
function of the affected individual to the point thatfunction of the affected individual to the point that
the individual cannot participate in everyday life.the individual cannot participate in everyday life.
• Hallmark: loss of contact with realityHallmark: loss of contact with reality
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
PsychotherapeuticsPsychotherapeutics
Affective DisordersAffective Disorders
• Major emotional disorders that impair theMajor emotional disorders that impair the
mental function of the affected individual tomental function of the affected individual to
the point that the individual cannotthe point that the individual cannot
participate in everyday life.participate in everyday life.
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
PsychotherapeuticsPsychotherapeutics
Affective DisordersAffective Disorders
• Mania: abnormally pronounced emotionsMania: abnormally pronounced emotions
• Depression: abnormally reduced emotionsDepression: abnormally reduced emotions
• Bipolar affective disorder: exhibits both maniaBipolar affective disorder: exhibits both mania
and depressionand depression
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
PsychotherapeuticsPsychotherapeutics
PathophysiologyPathophysiology
Biochemical ImbalanceBiochemical Imbalance
• Mental disorders are associated with abnormalMental disorders are associated with abnormal
levels of endogenous chemicals, such aslevels of endogenous chemicals, such as
neurotransmitters, in the brain.neurotransmitters, in the brain.
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
PsychotherapeuticsPsychotherapeutics
PathophysiologyPathophysiology
Biochemical ImbalanceBiochemical Imbalance
• Brain levels of certain catecholamines play anBrain levels of certain catecholamines play an
important role in maintaining mental health.important role in maintaining mental health.
– DopamineDopamine
– SerotoninSerotonin
– HistamineHistamine
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
PsychotherapeuticsPsychotherapeutics
PathophysiologyPathophysiology
Biochemical ImbalanceBiochemical Imbalance
• Other biochemicals are necessary for normalOther biochemicals are necessary for normal
mental function.mental function.
– GABAGABA
– acetylcholineacetylcholine
– lithiumlithium
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Etiology of DepressionEtiology of Depression
Biogenic Amine HypothesisBiogenic Amine Hypothesis
• Depression and mania are due to an alteration inDepression and mania are due to an alteration in
neuronal and synaptic catecholamine concentrationneuronal and synaptic catecholamine concentration
at adrenergic receptor sites in the brain.at adrenergic receptor sites in the brain.
– Depression: deficiency of catecholamine,Depression: deficiency of catecholamine,
especially norepinephrineespecially norepinephrine
– Mania: excess aminesMania: excess amines
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Instructors may wish to insertInstructors may wish to insert
EIC Image #45:EIC Image #45:
Biogenic Amine HypothesisBiogenic Amine Hypothesis
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Affective DisordersAffective Disorders
Drug CategoriesDrug Categories
• AntidepressantsAntidepressants
• tricyclics, tetracyclics, SSRIs, MAOIstricyclics, tetracyclics, SSRIs, MAOIs
• Antimanic AgentsAntimanic Agents
• lithiumlithium
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
AntidepressantsAntidepressants
Cyclic antidepressantsCyclic antidepressants
– tricyclicstricyclics
– tetracyclicstetracyclics
• Monoamine oxidase inhibitors (MAOIs)Monoamine oxidase inhibitors (MAOIs)
• Second-generation antidepressantsSecond-generation antidepressants
and SSRIsand SSRIs
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Cyclic AntidepressantsCyclic Antidepressants
• Tricyclic antidepressants—primary:Tricyclic antidepressants—primary:
amitriptyline (Elavil), doxepin (Sinequan),amitriptyline (Elavil), doxepin (Sinequan),
imipramine (Tofranil)imipramine (Tofranil)
• Tricyclic antidepressants—secondary:Tricyclic antidepressants—secondary:
desipramine (Norpramin), nortriptylinedesipramine (Norpramin), nortriptyline
(Aventyl), protriptyline (Vivactil)(Aventyl), protriptyline (Vivactil)
• Tetracyclic antidepressants:Tetracyclic antidepressants:
amoxapine (Asendin), maprotiline (Ludiomil)amoxapine (Asendin), maprotiline (Ludiomil)
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Cyclic AntidepressantsCyclic Antidepressants
Mechanism of ActionMechanism of Action
• Block reuptake of neurotransmitters, causingBlock reuptake of neurotransmitters, causing
accumulation at the nerve endings.accumulation at the nerve endings.
• It is thought that increasing concentrations ofIt is thought that increasing concentrations of
neurotransmitters will correct the abnormallyneurotransmitters will correct the abnormally
low levels that lead to depression.low levels that lead to depression.
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Cyclic AntidepressantsCyclic Antidepressants
Mechanism of Action—Drug EffectsMechanism of Action—Drug Effects
Blockade of norepinephrine:Blockade of norepinephrine:
– antidepressant, tremors, tachycardia, additiveantidepressant, tremors, tachycardia, additive
pressor effects with sympathomimetic drugspressor effects with sympathomimetic drugs
Blockade of serotonin:Blockade of serotonin:
– antidepressant, nausea, headache, anxiety,antidepressant, nausea, headache, anxiety,
sexual dysfunctionsexual dysfunction
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Cyclic AntidepressantsCyclic Antidepressants
Therapeutic UsesTherapeutic Uses
• DepressionDepression
• Childhood enuresis (imipramine)Childhood enuresis (imipramine)
• Obsessive-compulsive disordersObsessive-compulsive disorders
(clomipramine)(clomipramine)
• Adjunctive analgesicsAdjunctive analgesics
• Trigeminal neuralgiaTrigeminal neuralgia
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Cyclic AntidepressantsCyclic Antidepressants
Side EffectsSide Effects
• SedationSedation
• ImpotenceImpotence
• Orthostatic hypotensionOrthostatic hypotension
• Older patients:Older patients:
– dizziness, postural hypotension, constipation,dizziness, postural hypotension, constipation,
delayed micturation, edema, muscle tremorsdelayed micturation, edema, muscle tremors
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Tricyclic Antidepressants OverdoseTricyclic Antidepressants Overdose
• Lethal—70 to 80% die before reachingLethal—70 to 80% die before reaching
the hospitalthe hospital
• CNS and cardiovascular systems areCNS and cardiovascular systems are
mainly affectedmainly affected
• Death results from seizures or dysrhythmiasDeath results from seizures or dysrhythmias
• No specific antidoteNo specific antidote
– Decrease drug absorption with activated charcoalDecrease drug absorption with activated charcoal
– Speed elimination by alkalinizing urineSpeed elimination by alkalinizing urine
– Manage seizures and dysrhythmiasManage seizures and dysrhythmias
– Basic life supportBasic life support
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
AntidepressantsAntidepressants
Monoamine Oxidase Inhibitors: MAOIsMonoamine Oxidase Inhibitors: MAOIs
• Highly effectiveHighly effective
• Considered second-line treatment forConsidered second-line treatment for
depression not responsive to cyclicsdepression not responsive to cyclics
• Disadvantage: potential to causeDisadvantage: potential to cause
hypertensive crisis when taken with tyraminehypertensive crisis when taken with tyramine
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Antidepressants: MAOIsAntidepressants: MAOIs
• phenelzine (Nardil)phenelzine (Nardil)
• tranylcypromine (Parnate)tranylcypromine (Parnate)
• isocarboxazid (Marplan)isocarboxazid (Marplan)
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Antidepressants: MAOIsAntidepressants: MAOIs
Mechanism of ActionMechanism of Action
• Inhibit the MAO enzyme system in the CNSInhibit the MAO enzyme system in the CNS
• Amines (dopamine, serotonin,Amines (dopamine, serotonin,
norepinephrine) are not broken down,norepinephrine) are not broken down,
resulting in higher levels in the brainresulting in higher levels in the brain
• Result: alleviation of symptoms ofResult: alleviation of symptoms of
depressiondepression
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Antidepressants: MAOIsAntidepressants: MAOIs
Therapeutic UsesTherapeutic Uses
• Depression, especially types characterizedDepression, especially types characterized
by reverse vegetative symptoms such asby reverse vegetative symptoms such as
increased sleep and appetiteincreased sleep and appetite
• Depression that does not respond to otherDepression that does not respond to other
agents such as tricyclicsagents such as tricyclics
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Antidepressants: MAOIsAntidepressants: MAOIs
Side EffectsSide Effects
• Few side effects—orthostatic hypotensionFew side effects—orthostatic hypotension
most commonmost common
TachycardiaTachycardia PalpitationsPalpitations
DizzinessDizziness DrowsinessDrowsiness
InsomniaInsomnia HeadacheHeadache
AnorexiaAnorexia NauseaNausea
Blurred visionBlurred vision ImpotenceImpotence
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Antidepressants: MAOIsAntidepressants: MAOIs
OverdoseOverdose
• Symptoms appear 12 hours after ingestionSymptoms appear 12 hours after ingestion
• Tachycardia, circulatory collapse,Tachycardia, circulatory collapse,
seizures, comaseizures, coma
• Treatment: protect brain and heart,Treatment: protect brain and heart,
eliminate toxineliminate toxin
– Gastric lavageGastric lavage
– Urine acidificationUrine acidification
– HemodialysisHemodialysis
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Antidepressants: MAOIsAntidepressants: MAOIs
Hypertensive Crisis and TyramineHypertensive Crisis and Tyramine
• Ingestion of foods and/or drinks withIngestion of foods and/or drinks with
the amino acid TYRAMINE leads tothe amino acid TYRAMINE leads to
hypertensive crisis, which may leadhypertensive crisis, which may lead
to cerebral hemorrhage, stroke,to cerebral hemorrhage, stroke,
coma, or deathcoma, or death
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Antidepressants: MAOIsAntidepressants: MAOIs
Hypertensive Crisis and TyramineHypertensive Crisis and Tyramine
Avoid foods that contain tyramine!Avoid foods that contain tyramine!
• Aged, mature cheeses (cheddar, blue, Swiss)Aged, mature cheeses (cheddar, blue, Swiss)
• Smoked/pickled or aged meats, fish, poultrySmoked/pickled or aged meats, fish, poultry
(herring, sausage, corned beef, salami, pepperoni,(herring, sausage, corned beef, salami, pepperoni,
paté)paté)
• Yeast extractsYeast extracts
• Red wines (Chianti, burgundy, sherry, vermouth)Red wines (Chianti, burgundy, sherry, vermouth)
• Italian broad beans (fava beans)Italian broad beans (fava beans)
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Second-Generation AntidepressantsSecond-Generation Antidepressants
• NewerNewer
• Fewer side effects than tricyclics, but notFewer side effects than tricyclics, but not
superior in overall efficacy or onset of actionsuperior in overall efficacy or onset of action
– trazodone (Desyrel)trazodone (Desyrel)
– bupropion (Wellbutrin, Zyban)bupropion (Wellbutrin, Zyban)
– selective serotonin reuptake inhibitors (SSRIs)selective serotonin reuptake inhibitors (SSRIs)
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Second-GenerationSecond-Generation
Antidepressants and SSRIsAntidepressants and SSRIs
Mechanism of ActionMechanism of Action
• Selectively inhibit serotonin reuptakeSelectively inhibit serotonin reuptake
• Little or no effect on norepinephrine orLittle or no effect on norepinephrine or
dopamine reuptakedopamine reuptake
• Results in increased serotoninResults in increased serotonin
concentrations at nerve endingsconcentrations at nerve endings
Advantage over tricyclics and MAOIs:Advantage over tricyclics and MAOIs:
Little or no effect on cardiovascular systemLittle or no effect on cardiovascular system
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Second-Generation AntidepressantsSecond-Generation Antidepressants
Therapeutic UsesTherapeutic Uses
• Used for depression—very few serious side effectsUsed for depression—very few serious side effects
• Bipolar affective disorderBipolar affective disorder
• ObesityObesity
• Eating disordersEating disorders
• Obsessive-compulsive disorderObsessive-compulsive disorder
• Panic attacksPanic attacks
• MyoclonusMyoclonus
• Treatment of various substance abuse problemsTreatment of various substance abuse problems
(bupropion [Zyban] is used for smoking cessation(bupropion [Zyban] is used for smoking cessation
treatment)treatment)
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Second-Generation AntidepressantsSecond-Generation Antidepressants
Side EffectsSide Effects
Body SystemBody System EffectsEffects
CNSCNS Headache, dizziness,Headache, dizziness,
tremor, nervousness,tremor, nervousness,
insomnia, fatigueinsomnia, fatigue
GIGI Nausea, diarrhea,Nausea, diarrhea,
constipation, dry mouthconstipation, dry mouth
OtherOther Sweating, sexualSweating, sexual
dysfunctiondysfunction
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Second-Generation AntidepressantsSecond-Generation Antidepressants
Drug InteractionsDrug Interactions
• Highly bound to plasma proteinsHighly bound to plasma proteins
• Compete with other protein-binding drugs,Compete with other protein-binding drugs,
resulting in more free, unbound drug toresulting in more free, unbound drug to
cause a more pronounced drug effectcause a more pronounced drug effect
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
AntipsychoticsAntipsychotics
• Drugs used to treat serious mental illnessDrugs used to treat serious mental illness
• Behavioral problems or psychotic disordersBehavioral problems or psychotic disorders
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
AntipsychoticsAntipsychotics
• Thioxanthenes: chlorprothixene, thiothixeneThioxanthenes: chlorprothixene, thiothixene
(Navane)(Navane)
• Butyrophenones: haloperidol (Haldol)Butyrophenones: haloperidol (Haldol)
• Dihydroindolones: molindone (Moban)Dihydroindolones: molindone (Moban)
• Dibenzoxazepine: loxapine (Loxitane)Dibenzoxazepine: loxapine (Loxitane)
• Phenothiazines: three structural groupsPhenothiazines: three structural groups
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
AntipsychoticsAntipsychotics
Phenothiazine Structural GroupsPhenothiazine Structural Groups
• Aliphatic: chlorpromazine (Thorazine),Aliphatic: chlorpromazine (Thorazine),
triflupromazine (Vesprin)triflupromazine (Vesprin)
• Piperidine: mesoridazine (Serentil),Piperidine: mesoridazine (Serentil),
thioridazine (Mellaril)thioridazine (Mellaril)
• Piperazine: fluphenazine (Prolixin),Piperazine: fluphenazine (Prolixin),
perphenazine (Trilafon), prochlorperazineperphenazine (Trilafon), prochlorperazine
(Compazine), trifluoperazine (Stelazine)(Compazine), trifluoperazine (Stelazine)
Largest group of psychotropic agentsLargest group of psychotropic agents
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
AntipsychoticsAntipsychotics
Atypical AntipsychoticsAtypical Antipsychotics
• clozapine (Clozaril)clozapine (Clozaril)
• risperidone (Risperdal)risperidone (Risperdal)
• olanzapine (Zyprexa)olanzapine (Zyprexa)
• quetiapine (Seroquel)quetiapine (Seroquel)
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Antipsychotics: Mechanism of ActionAntipsychotics: Mechanism of Action
• Block dopamine receptors in the brainBlock dopamine receptors in the brain
(limbic system, basal ganglia)—areas(limbic system, basal ganglia)—areas
associated with emotion, cognitive function,associated with emotion, cognitive function,
motor functionmotor function
• Dopamine levels in the CNS are decreasedDopamine levels in the CNS are decreased
• Result: tranquilizing effect in psychoticResult: tranquilizing effect in psychotic
patientspatients
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Antipsychotics: Mechanism of ActionAntipsychotics: Mechanism of Action
• The newer, atypical antipsychotics also blockThe newer, atypical antipsychotics also block
specific serotonin receptors (serotonin-2specific serotonin receptors (serotonin-2
[5HT2] receptors).[5HT2] receptors).
• This is responsible for their improvedThis is responsible for their improved
efficacy and safety profiles.efficacy and safety profiles.
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Antipsychotics: Drug EffectsAntipsychotics: Drug Effects
• Block dopamine receptors in CNSBlock dopamine receptors in CNS
• Block alpha receptors (causing hypertension,Block alpha receptors (causing hypertension,
other cardiovascular effects)other cardiovascular effects)
• Block histamine receptors (causingBlock histamine receptors (causing
anticholinergic effects)anticholinergic effects)
• Block serotoninBlock serotonin
• Also function as antiemeticsAlso function as antiemetics
• Antianxiety effectsAntianxiety effects
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Antipsychotics: Therapeutic UsesAntipsychotics: Therapeutic Uses
• Treatment of serious mental illnesses:Treatment of serious mental illnesses:
– Bipolar affective disorderBipolar affective disorder
– Depressive and drug-induced psychosesDepressive and drug-induced psychoses
– SchizophreniaSchizophrenia
– AutismAutism
• Movement disorders (such as Tourette’sMovement disorders (such as Tourette’s
syndrome)syndrome)
• Some medical conditionsSome medical conditions
– Nausea, intractable hiccupsNausea, intractable hiccups
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Antipsychotics: Side EffectsAntipsychotics: Side Effects
Body SystemBody System EffectsEffects
CNSCNS Sedation, deliriumSedation, delirium
CardiovascularCardiovascular Orthostatic hypotension,Orthostatic hypotension,
syncope, dizziness,syncope, dizziness,
ECG changesECG changes
DermatologicDermatologic Photosensitivity, skin rash,Photosensitivity, skin rash,
hyperpigmentation, pruritushyperpigmentation, pruritus
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Antipsychotics: Side EffectsAntipsychotics: Side Effects
Body SystemBody System EffectsEffects
GIGI Dry mouth, constipationDry mouth, constipation
GUGU Urinary hesitancy orUrinary hesitancy or
retention, impaired erectionretention, impaired erection
HematologicHematologic Leukopenia andLeukopenia and
agranulocytosisagranulocytosis
Metabolic/endocrineMetabolic/endocrine Galactorrhea, irregularGalactorrhea, irregular
mensesmenses
increased appetite,increased appetite,
polydipsiapolydipsia
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Psychotherapeutic Agents:Psychotherapeutic Agents:
Nursing ImplicationsNursing Implications
• Before beginning therapy, assess both theBefore beginning therapy, assess both the
physical and emotional status of patientsphysical and emotional status of patients
• Obtain baseline VS, including postural BPObtain baseline VS, including postural BP
readingsreadings
• Obtain liver and renal function tests (andObtain liver and renal function tests (and
baseline platelet levels for MAOIs)baseline platelet levels for MAOIs)
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Psychotherapeutic Agents:Psychotherapeutic Agents:
Nursing ImplicationsNursing Implications
• Assess for possible contraindications toAssess for possible contraindications to
therapy, cautious use, and potential drugtherapy, cautious use, and potential drug
interactionsinteractions
• Assess LOC, mental alertness, potentialAssess LOC, mental alertness, potential
for injury to self and othersfor injury to self and others
• Check the patient’s mouth to make sureCheck the patient’s mouth to make sure
oral doses are swallowedoral doses are swallowed
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Psychotherapeutic Agents:Psychotherapeutic Agents:
Nursing ImplicationsNursing Implications
• Provide simple explanations about the drug,Provide simple explanations about the drug,
its effects, and the length of time beforeits effects, and the length of time before
therapeutic effects can be expectedtherapeutic effects can be expected
• Abrupt withdrawal should be avoidedAbrupt withdrawal should be avoided
• Advise patients to change positions slowlyAdvise patients to change positions slowly
to avoid postural hypotension and possibleto avoid postural hypotension and possible
injuryinjury
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Psychotherapeutic Agents:Psychotherapeutic Agents:
Nursing ImplicationsNursing Implications
• The combination of drug therapy andThe combination of drug therapy and
psychotherapy is emphasized becausepsychotherapy is emphasized because
patients need to learn and acquire morepatients need to learn and acquire more
effective coping skillseffective coping skills
• Only small amounts of medications shouldOnly small amounts of medications should
be dispensed at a time to minimize the riskbe dispensed at a time to minimize the risk
of suicide attemptsof suicide attempts
• Simultaneous use of these agents withSimultaneous use of these agents with
alcohol or other CNS depressants canalcohol or other CNS depressants can
be fatalbe fatal
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Psychotherapeutic Agents:Psychotherapeutic Agents:
Nursing ImplicationsNursing Implications
AntidepressantsAntidepressants
• Many cautions, contraindications, and interactionsMany cautions, contraindications, and interactions
exist pertaining to the use of antidepressants.exist pertaining to the use of antidepressants.
• Inform patients that it may take 1 to 3, even 4,Inform patients that it may take 1 to 3, even 4,
weeks to see therapeutic effects.weeks to see therapeutic effects.
• Monitor patients closely during this time andMonitor patients closely during this time and
provide support.provide support.
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Psychotherapeutic Agents:Psychotherapeutic Agents:
Nursing ImplicationsNursing Implications
AntidepressantsAntidepressants
• Sedation often occurs with tricyclic therapy; notifySedation often occurs with tricyclic therapy; notify
physician if this lasts more than 2 weeks.physician if this lasts more than 2 weeks.
• Assist elderly or weakened patients with ambulationAssist elderly or weakened patients with ambulation
and other activities as falls may occur due toand other activities as falls may occur due to
drowsiness or postural hypotension.drowsiness or postural hypotension.
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Psychotherapeutic Agents:Psychotherapeutic Agents:
Nursing ImplicationsNursing Implications
AntidepressantsAntidepressants
• Tricyclics may need to be weaned and discontinuedTricyclics may need to be weaned and discontinued
before undergoing surgery to avoid interactions withbefore undergoing surgery to avoid interactions with
anesthetic agents.anesthetic agents.
• Monitor for side effects and discuss with patients.Monitor for side effects and discuss with patients.
• Encourage patients to wear medication ID badgesEncourage patients to wear medication ID badges
naming the agent being taken.naming the agent being taken.
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Psychotherapeutic Agents:Psychotherapeutic Agents:
Nursing ImplicationsNursing Implications
AntidepressantsAntidepressants
• Caffeine and cigarette smoking may decreaseCaffeine and cigarette smoking may decrease
effectiveness of medication therapyeffectiveness of medication therapy
• Instruct patients and family regarding tyramine-Instruct patients and family regarding tyramine-
containing foods and signs and symptoms ofcontaining foods and signs and symptoms of
hypertensive crisishypertensive crisis
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Psychotherapeutic Agents:Psychotherapeutic Agents:
Nursing ImplicationsNursing Implications
Antipsychotics—PhenothiazinesAntipsychotics—Phenothiazines
• Instruct patients to wear sunscreen due toInstruct patients to wear sunscreen due to
photosensitivityphotosensitivity
• Avoid taking antacids or antidiarrheal preparationsAvoid taking antacids or antidiarrheal preparations
within 1 hour of a dosewithin 1 hour of a dose
• Do not take alcohol or other CNS depressantsDo not take alcohol or other CNS depressants
with these medicationswith these medications
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Psychotherapeutic Agents:Psychotherapeutic Agents:
Nursing ImplicationsNursing Implications
Antipsychotics—PhenothiazinesAntipsychotics—Phenothiazines
• Long-term haloperidol therapy may result in tremors,Long-term haloperidol therapy may result in tremors,
nausea, vomiting, or uncontrollable shaking of smallnausea, vomiting, or uncontrollable shaking of small
muscle groups; these symptoms should be reportedmuscle groups; these symptoms should be reported
to the physicianto the physician
• Oral forms may be taken with meals to decreaseOral forms may be taken with meals to decrease
GI upsetGI upset
• These agents may cause drowsiness, dizziness, orThese agents may cause drowsiness, dizziness, or
fainting; instruct patients to change positions slowlyfainting; instruct patients to change positions slowly
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Psychotherapeutic Agents:Psychotherapeutic Agents:
Nursing ImplicationsNursing Implications
Monitor for therapeutic effects:Monitor for therapeutic effects:
• Monitor mental alertness, cognition, affect,Monitor mental alertness, cognition, affect,
mood,ability to carry out activities of dailymood,ability to carry out activities of daily
living, appetite, and sleep patternsliving, appetite, and sleep patterns
• Monitor the patient’s potential for self-injuryMonitor the patient’s potential for self-injury
during the delay between the start of therapyduring the delay between the start of therapy
and symptomatic improvementand symptomatic improvement
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Psychotherapeutic Agents:Psychotherapeutic Agents:
Nursing ImplicationsNursing Implications
Monitor for therapeutic effectsMonitor for therapeutic effects
• For antidepressants:For antidepressants:
– Improved sleep patterns and nutrition, increasedImproved sleep patterns and nutrition, increased
feelings of self-esteem, decreased feeling offeelings of self-esteem, decreased feeling of
hopelessness, increased interest in self andhopelessness, increased interest in self and
appearance, increased interest in daily activities,appearance, increased interest in daily activities,
fewer depressive manifestations or suicidalfewer depressive manifestations or suicidal
thoughts or ideationsthoughts or ideations
Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved.
Psychotherapeutic Agents:Psychotherapeutic Agents:
Nursing ImplicationsNursing Implications
Monitor for therapeutic effectsMonitor for therapeutic effects
• For antipsychotics:For antipsychotics:
– Improved mood and affect, alleviation ofImproved mood and affect, alleviation of
psychotic symptoms and episodespsychotic symptoms and episodes
– Decrease in hallucinations, paranoia, delusions,Decrease in hallucinations, paranoia, delusions,
garbled speech, inability to copegarbled speech, inability to cope

Weitere ähnliche Inhalte

Was ist angesagt?

General anesthetic and pre anesthetics
General anesthetic and pre anestheticsGeneral anesthetic and pre anesthetics
General anesthetic and pre anestheticsGourav Singh
 
Hypnotics and sedatives slideshare
Hypnotics and sedatives   slideshareHypnotics and sedatives   slideshare
Hypnotics and sedatives slidesharePurna Nagasree K
 
Psychotherapeutics
PsychotherapeuticsPsychotherapeutics
PsychotherapeuticsRichard Asare
 
1.1 introduction of haemodynamics and electrophysiology of heart
1.1 introduction of haemodynamics and electrophysiology of heart1.1 introduction of haemodynamics and electrophysiology of heart
1.1 introduction of haemodynamics and electrophysiology of heartArunachalam Muthuraman
 
Drugs acting in uterus - stimulant and relaxant
Drugs acting in uterus - stimulant and relaxant Drugs acting in uterus - stimulant and relaxant
Drugs acting in uterus - stimulant and relaxant Dheeraj Saini
 
Antimanic drugs
Antimanic drugsAntimanic drugs
Antimanic drugsPranatiChavan
 
CNS- anticonvulsants or Antiepileptics
CNS-  anticonvulsants or AntiepilepticsCNS-  anticonvulsants or Antiepileptics
CNS- anticonvulsants or AntiepilepticsPurna Nagasree K
 
Cardiac glycoside PHARMACOLOGY
Cardiac glycoside PHARMACOLOGYCardiac glycoside PHARMACOLOGY
Cardiac glycoside PHARMACOLOGYBindu Kundu
 
SAR of H1 Receptor Antagonists..
SAR of H1 Receptor Antagonists..SAR of H1 Receptor Antagonists..
SAR of H1 Receptor Antagonists..Joydeep Ganguly
 
Vasodilators - Medicinal chemistry for B.Pharm.
Vasodilators - Medicinal chemistry for B.Pharm.Vasodilators - Medicinal chemistry for B.Pharm.
Vasodilators - Medicinal chemistry for B.Pharm.Purna Nagasree K
 
UNIT III_cholinergic neurotransmitter agonist
UNIT III_cholinergic neurotransmitter agonistUNIT III_cholinergic neurotransmitter agonist
UNIT III_cholinergic neurotransmitter agonistSONALI PAWAR
 
1 st unit h2 antagonist
1 st unit h2 antagonist1 st unit h2 antagonist
1 st unit h2 antagonistNikithaGopalpet
 
Sedatives and hypnotics
Sedatives and hypnotics Sedatives and hypnotics
Sedatives and hypnotics Madan Sigdel
 
Antidepressants -pharmacology
Antidepressants -pharmacologyAntidepressants -pharmacology
Antidepressants -pharmacologypavithra vinayak
 
Sedative Hypnotic(Act on gaba, Na, K)
Sedative Hypnotic(Act on gaba, Na, K)Sedative Hypnotic(Act on gaba, Na, K)
Sedative Hypnotic(Act on gaba, Na, K)BikashAdhikari26
 
chlorpromazine(Antipsychotic Drug)
chlorpromazine(Antipsychotic Drug)chlorpromazine(Antipsychotic Drug)
chlorpromazine(Antipsychotic Drug)Syed Sunny
 

Was ist angesagt? (20)

General anesthetic and pre anesthetics
General anesthetic and pre anestheticsGeneral anesthetic and pre anesthetics
General anesthetic and pre anesthetics
 
Hypnotics and sedatives slideshare
Hypnotics and sedatives   slideshareHypnotics and sedatives   slideshare
Hypnotics and sedatives slideshare
 
Psychotherapeutics
PsychotherapeuticsPsychotherapeutics
Psychotherapeutics
 
ANTIDEPRESSANTS
ANTIDEPRESSANTSANTIDEPRESSANTS
ANTIDEPRESSANTS
 
1.1 introduction of haemodynamics and electrophysiology of heart
1.1 introduction of haemodynamics and electrophysiology of heart1.1 introduction of haemodynamics and electrophysiology of heart
1.1 introduction of haemodynamics and electrophysiology of heart
 
Drugs acting in uterus - stimulant and relaxant
Drugs acting in uterus - stimulant and relaxant Drugs acting in uterus - stimulant and relaxant
Drugs acting in uterus - stimulant and relaxant
 
Antimanic drugs
Antimanic drugsAntimanic drugs
Antimanic drugs
 
CNS- anticonvulsants or Antiepileptics
CNS-  anticonvulsants or AntiepilepticsCNS-  anticonvulsants or Antiepileptics
CNS- anticonvulsants or Antiepileptics
 
Cardiac glycoside PHARMACOLOGY
Cardiac glycoside PHARMACOLOGYCardiac glycoside PHARMACOLOGY
Cardiac glycoside PHARMACOLOGY
 
Hallucinogens pharmacology
Hallucinogens pharmacologyHallucinogens pharmacology
Hallucinogens pharmacology
 
SAR of H1 Receptor Antagonists..
SAR of H1 Receptor Antagonists..SAR of H1 Receptor Antagonists..
SAR of H1 Receptor Antagonists..
 
Vasodilators - Medicinal chemistry for B.Pharm.
Vasodilators - Medicinal chemistry for B.Pharm.Vasodilators - Medicinal chemistry for B.Pharm.
Vasodilators - Medicinal chemistry for B.Pharm.
 
UNIT III_cholinergic neurotransmitter agonist
UNIT III_cholinergic neurotransmitter agonistUNIT III_cholinergic neurotransmitter agonist
UNIT III_cholinergic neurotransmitter agonist
 
1 st unit h2 antagonist
1 st unit h2 antagonist1 st unit h2 antagonist
1 st unit h2 antagonist
 
Diuretics
DiureticsDiuretics
Diuretics
 
Sedatives and hypnotics
Sedatives and hypnotics Sedatives and hypnotics
Sedatives and hypnotics
 
Antidepressants -pharmacology
Antidepressants -pharmacologyAntidepressants -pharmacology
Antidepressants -pharmacology
 
Sedative Hypnotic(Act on gaba, Na, K)
Sedative Hypnotic(Act on gaba, Na, K)Sedative Hypnotic(Act on gaba, Na, K)
Sedative Hypnotic(Act on gaba, Na, K)
 
chlorpromazine(Antipsychotic Drug)
chlorpromazine(Antipsychotic Drug)chlorpromazine(Antipsychotic Drug)
chlorpromazine(Antipsychotic Drug)
 
Antimanic drugs
Antimanic drugsAntimanic drugs
Antimanic drugs
 

Ă„hnlich wie psychotherapeutic agents

cholinergic blockers
cholinergic blockerscholinergic blockers
cholinergic blockersDENNIS MUĂ‘OZ
 
cholinergic blockers
cholinergic blockerscholinergic blockers
cholinergic blockersDENNIS MUĂ‘OZ
 
CNS Depressants
CNS DepressantsCNS Depressants
CNS DepressantsUmair hanif
 
Conscious sedation
Conscious sedationConscious sedation
Conscious sedationMEEQAT HOSPITAL
 
Conscious sedation
Conscious sedationConscious sedation
Conscious sedationMEEQAT HOSPITAL
 
Psychiatric nursing review
Psychiatric nursing  reviewPsychiatric nursing  review
Psychiatric nursing reviewgrey clemente
 
Depression & Anti-depressants
Depression & Anti-depressantsDepression & Anti-depressants
Depression & Anti-depressantsDrAshok Batham
 
Mania,depression and Schizophrenia
Mania,depression and SchizophreniaMania,depression and Schizophrenia
Mania,depression and SchizophreniaMirza Anwar Baig
 
PSYCHOLOGY Chapter 12 Psychological Disorders
PSYCHOLOGY Chapter 12  Psychological DisordersPSYCHOLOGY Chapter 12  Psychological Disorders
PSYCHOLOGY Chapter 12 Psychological Disordersprofessorjcc
 
Abnormality: Biological treatments AS
Abnormality: Biological treatments ASAbnormality: Biological treatments AS
Abnormality: Biological treatments ASJill Jan
 
Antidepressants powerpoint
Antidepressants powerpointAntidepressants powerpoint
Antidepressants powerpointAllegra Lange
 
Gardner academy jul_2012,_drug_use_and_abuse-1[1]
Gardner academy jul_2012,_drug_use_and_abuse-1[1]Gardner academy jul_2012,_drug_use_and_abuse-1[1]
Gardner academy jul_2012,_drug_use_and_abuse-1[1]TeenMentalHealth.org
 
Medicinal Chemistry
Medicinal ChemistryMedicinal Chemistry
Medicinal ChemistryPinaki Behera
 
depression (Psychiatric disorder) .pptx
depression (Psychiatric disorder)  .pptxdepression (Psychiatric disorder)  .pptx
depression (Psychiatric disorder) .pptxAman Kumar
 
Mental illness1098
Mental illness1098Mental illness1098
Mental illness1098Ashish Tiwari
 

Ă„hnlich wie psychotherapeutic agents (20)

cns depressants
cns depressantscns depressants
cns depressants
 
cholinergic blockers
cholinergic blockerscholinergic blockers
cholinergic blockers
 
cholinergic blockers
cholinergic blockerscholinergic blockers
cholinergic blockers
 
CNS Depressants
CNS DepressantsCNS Depressants
CNS Depressants
 
Conscious sedation
Conscious sedationConscious sedation
Conscious sedation
 
Conscious sedation
Conscious sedationConscious sedation
Conscious sedation
 
Psychiatric nursing review
Psychiatric nursing  reviewPsychiatric nursing  review
Psychiatric nursing review
 
Dissociative Anaesthetics
Dissociative AnaestheticsDissociative Anaesthetics
Dissociative Anaesthetics
 
Depression & Anti-depressants
Depression & Anti-depressantsDepression & Anti-depressants
Depression & Anti-depressants
 
opioid analgesics
opioid analgesicsopioid analgesics
opioid analgesics
 
Mania,depression and Schizophrenia
Mania,depression and SchizophreniaMania,depression and Schizophrenia
Mania,depression and Schizophrenia
 
PSYCHOLOGY Chapter 12 Psychological Disorders
PSYCHOLOGY Chapter 12  Psychological DisordersPSYCHOLOGY Chapter 12  Psychological Disorders
PSYCHOLOGY Chapter 12 Psychological Disorders
 
Abnormality: Biological treatments AS
Abnormality: Biological treatments ASAbnormality: Biological treatments AS
Abnormality: Biological treatments AS
 
Antidepressants powerpoint
Antidepressants powerpointAntidepressants powerpoint
Antidepressants powerpoint
 
Introduction of illicit substances
Introduction of illicit substancesIntroduction of illicit substances
Introduction of illicit substances
 
adrenergic blockers
adrenergic blockersadrenergic blockers
adrenergic blockers
 
Gardner academy jul_2012,_drug_use_and_abuse-1[1]
Gardner academy jul_2012,_drug_use_and_abuse-1[1]Gardner academy jul_2012,_drug_use_and_abuse-1[1]
Gardner academy jul_2012,_drug_use_and_abuse-1[1]
 
Medicinal Chemistry
Medicinal ChemistryMedicinal Chemistry
Medicinal Chemistry
 
depression (Psychiatric disorder) .pptx
depression (Psychiatric disorder)  .pptxdepression (Psychiatric disorder)  .pptx
depression (Psychiatric disorder) .pptx
 
Mental illness1098
Mental illness1098Mental illness1098
Mental illness1098
 

Mehr von DENNIS MUĂ‘OZ (20)

Nursing Core Competency Standards 2012.pdf
Nursing Core Competency Standards 2012.pdfNursing Core Competency Standards 2012.pdf
Nursing Core Competency Standards 2012.pdf
 
anti hypertensives
anti hypertensivesanti hypertensives
anti hypertensives
 
pharmacologic principles
pharmacologic principlespharmacologic principles
pharmacologic principles
 
bronchodilators
bronchodilatorsbronchodilators
bronchodilators
 
antihistamines
antihistaminesantihistamines
antihistamines
 
weathering, soil, and erosion
weathering, soil, and erosionweathering, soil, and erosion
weathering, soil, and erosion
 
mountains
mountainsmountains
mountains
 
earthquake
earthquakeearthquake
earthquake
 
the active earth
the active earththe active earth
the active earth
 
energy resources
energy resourcesenergy resources
energy resources
 
geologic time
geologic timegeologic time
geologic time
 
climate change
climate changeclimate change
climate change
 
coastlines
coastlinescoastlines
coastlines
 
coastline
coastlinecoastline
coastline
 
ocean
oceanocean
ocean
 
dessert
dessertdessert
dessert
 
mountains
mountainsmountains
mountains
 
wind
windwind
wind
 
water supply and demand
water supply and demandwater supply and demand
water supply and demand
 
freshwater
freshwater freshwater
freshwater
 

KĂĽrzlich hochgeladen

The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfSreeja Cherukuru
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...saminamagar
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingArunagarwal328757
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 

KĂĽrzlich hochgeladen (20)

The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdfLippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
Lippincott Microcards_ Microbiology Flash Cards-LWW (2015).pdf
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Pharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, PricingPharmaceutical Marketting: Unit-5, Pricing
Pharmaceutical Marketting: Unit-5, Pricing
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 

psychotherapeutic agents

  • 1. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Psychotherapeutic AgentsPsychotherapeutic Agents AntidepressantsAntidepressants and Antipsychoticsand Antipsychotics
  • 2. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. PsychotherapeuticsPsychotherapeutics • The therapy of emotional and mentalThe therapy of emotional and mental disordersdisorders
  • 3. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. PsychotherapeuticsPsychotherapeutics • AnxietyAnxiety • GriefGrief • DepressionDepression are normal human emotionsare normal human emotions
  • 4. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. PsychotherapeuticsPsychotherapeutics • The ability to cope with these emotions canThe ability to cope with these emotions can range from occasional depression or anxietyrange from occasional depression or anxiety to constant emotional distress to the pointto constant emotional distress to the point ofinterfering with the ability to carry onofinterfering with the ability to carry on normal daily living.normal daily living.
  • 5. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. PsychotherapeuticsPsychotherapeutics • When these emotions significantly affect anWhen these emotions significantly affect an individual’s ability to carry out normal dailyindividual’s ability to carry out normal daily functions, treatment with a psychotherapeuticfunctions, treatment with a psychotherapeutic drug is a possible option.drug is a possible option.
  • 6. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. PsychotherapeuticsPsychotherapeutics Three main emotional and mental disorders:Three main emotional and mental disorders: • PsychosesPsychoses • Affective disordersAffective disorders • AnxietyAnxiety
  • 7. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. PsychotherapeuticsPsychotherapeutics PsychosisPsychosis • A major emotional disorder that impairs the mentalA major emotional disorder that impairs the mental function of the affected individual to the point thatfunction of the affected individual to the point that the individual cannot participate in everyday life.the individual cannot participate in everyday life. • Hallmark: loss of contact with realityHallmark: loss of contact with reality
  • 8. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. PsychotherapeuticsPsychotherapeutics Affective DisordersAffective Disorders • Major emotional disorders that impair theMajor emotional disorders that impair the mental function of the affected individual tomental function of the affected individual to the point that the individual cannotthe point that the individual cannot participate in everyday life.participate in everyday life.
  • 9. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. PsychotherapeuticsPsychotherapeutics Affective DisordersAffective Disorders • Mania: abnormally pronounced emotionsMania: abnormally pronounced emotions • Depression: abnormally reduced emotionsDepression: abnormally reduced emotions • Bipolar affective disorder: exhibits both maniaBipolar affective disorder: exhibits both mania and depressionand depression
  • 10. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. PsychotherapeuticsPsychotherapeutics PathophysiologyPathophysiology Biochemical ImbalanceBiochemical Imbalance • Mental disorders are associated with abnormalMental disorders are associated with abnormal levels of endogenous chemicals, such aslevels of endogenous chemicals, such as neurotransmitters, in the brain.neurotransmitters, in the brain.
  • 11. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. PsychotherapeuticsPsychotherapeutics PathophysiologyPathophysiology Biochemical ImbalanceBiochemical Imbalance • Brain levels of certain catecholamines play anBrain levels of certain catecholamines play an important role in maintaining mental health.important role in maintaining mental health. – DopamineDopamine – SerotoninSerotonin – HistamineHistamine
  • 12. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. PsychotherapeuticsPsychotherapeutics PathophysiologyPathophysiology Biochemical ImbalanceBiochemical Imbalance • Other biochemicals are necessary for normalOther biochemicals are necessary for normal mental function.mental function. – GABAGABA – acetylcholineacetylcholine – lithiumlithium
  • 13. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Etiology of DepressionEtiology of Depression Biogenic Amine HypothesisBiogenic Amine Hypothesis • Depression and mania are due to an alteration inDepression and mania are due to an alteration in neuronal and synaptic catecholamine concentrationneuronal and synaptic catecholamine concentration at adrenergic receptor sites in the brain.at adrenergic receptor sites in the brain. – Depression: deficiency of catecholamine,Depression: deficiency of catecholamine, especially norepinephrineespecially norepinephrine – Mania: excess aminesMania: excess amines
  • 14. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Instructors may wish to insertInstructors may wish to insert EIC Image #45:EIC Image #45: Biogenic Amine HypothesisBiogenic Amine Hypothesis
  • 15. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Affective DisordersAffective Disorders Drug CategoriesDrug Categories • AntidepressantsAntidepressants • tricyclics, tetracyclics, SSRIs, MAOIstricyclics, tetracyclics, SSRIs, MAOIs • Antimanic AgentsAntimanic Agents • lithiumlithium
  • 16. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. AntidepressantsAntidepressants Cyclic antidepressantsCyclic antidepressants – tricyclicstricyclics – tetracyclicstetracyclics • Monoamine oxidase inhibitors (MAOIs)Monoamine oxidase inhibitors (MAOIs) • Second-generation antidepressantsSecond-generation antidepressants and SSRIsand SSRIs
  • 17. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Cyclic AntidepressantsCyclic Antidepressants • Tricyclic antidepressants—primary:Tricyclic antidepressants—primary: amitriptyline (Elavil), doxepin (Sinequan),amitriptyline (Elavil), doxepin (Sinequan), imipramine (Tofranil)imipramine (Tofranil) • Tricyclic antidepressants—secondary:Tricyclic antidepressants—secondary: desipramine (Norpramin), nortriptylinedesipramine (Norpramin), nortriptyline (Aventyl), protriptyline (Vivactil)(Aventyl), protriptyline (Vivactil) • Tetracyclic antidepressants:Tetracyclic antidepressants: amoxapine (Asendin), maprotiline (Ludiomil)amoxapine (Asendin), maprotiline (Ludiomil)
  • 18. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Cyclic AntidepressantsCyclic Antidepressants Mechanism of ActionMechanism of Action • Block reuptake of neurotransmitters, causingBlock reuptake of neurotransmitters, causing accumulation at the nerve endings.accumulation at the nerve endings. • It is thought that increasing concentrations ofIt is thought that increasing concentrations of neurotransmitters will correct the abnormallyneurotransmitters will correct the abnormally low levels that lead to depression.low levels that lead to depression.
  • 19. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Cyclic AntidepressantsCyclic Antidepressants Mechanism of Action—Drug EffectsMechanism of Action—Drug Effects Blockade of norepinephrine:Blockade of norepinephrine: – antidepressant, tremors, tachycardia, additiveantidepressant, tremors, tachycardia, additive pressor effects with sympathomimetic drugspressor effects with sympathomimetic drugs Blockade of serotonin:Blockade of serotonin: – antidepressant, nausea, headache, anxiety,antidepressant, nausea, headache, anxiety, sexual dysfunctionsexual dysfunction
  • 20. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Cyclic AntidepressantsCyclic Antidepressants Therapeutic UsesTherapeutic Uses • DepressionDepression • Childhood enuresis (imipramine)Childhood enuresis (imipramine) • Obsessive-compulsive disordersObsessive-compulsive disorders (clomipramine)(clomipramine) • Adjunctive analgesicsAdjunctive analgesics • Trigeminal neuralgiaTrigeminal neuralgia
  • 21. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Cyclic AntidepressantsCyclic Antidepressants Side EffectsSide Effects • SedationSedation • ImpotenceImpotence • Orthostatic hypotensionOrthostatic hypotension • Older patients:Older patients: – dizziness, postural hypotension, constipation,dizziness, postural hypotension, constipation, delayed micturation, edema, muscle tremorsdelayed micturation, edema, muscle tremors
  • 22. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Tricyclic Antidepressants OverdoseTricyclic Antidepressants Overdose • Lethal—70 to 80% die before reachingLethal—70 to 80% die before reaching the hospitalthe hospital • CNS and cardiovascular systems areCNS and cardiovascular systems are mainly affectedmainly affected • Death results from seizures or dysrhythmiasDeath results from seizures or dysrhythmias • No specific antidoteNo specific antidote – Decrease drug absorption with activated charcoalDecrease drug absorption with activated charcoal – Speed elimination by alkalinizing urineSpeed elimination by alkalinizing urine – Manage seizures and dysrhythmiasManage seizures and dysrhythmias – Basic life supportBasic life support
  • 23. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. AntidepressantsAntidepressants Monoamine Oxidase Inhibitors: MAOIsMonoamine Oxidase Inhibitors: MAOIs • Highly effectiveHighly effective • Considered second-line treatment forConsidered second-line treatment for depression not responsive to cyclicsdepression not responsive to cyclics • Disadvantage: potential to causeDisadvantage: potential to cause hypertensive crisis when taken with tyraminehypertensive crisis when taken with tyramine
  • 24. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Antidepressants: MAOIsAntidepressants: MAOIs • phenelzine (Nardil)phenelzine (Nardil) • tranylcypromine (Parnate)tranylcypromine (Parnate) • isocarboxazid (Marplan)isocarboxazid (Marplan)
  • 25. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Antidepressants: MAOIsAntidepressants: MAOIs Mechanism of ActionMechanism of Action • Inhibit the MAO enzyme system in the CNSInhibit the MAO enzyme system in the CNS • Amines (dopamine, serotonin,Amines (dopamine, serotonin, norepinephrine) are not broken down,norepinephrine) are not broken down, resulting in higher levels in the brainresulting in higher levels in the brain • Result: alleviation of symptoms ofResult: alleviation of symptoms of depressiondepression
  • 26. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Antidepressants: MAOIsAntidepressants: MAOIs Therapeutic UsesTherapeutic Uses • Depression, especially types characterizedDepression, especially types characterized by reverse vegetative symptoms such asby reverse vegetative symptoms such as increased sleep and appetiteincreased sleep and appetite • Depression that does not respond to otherDepression that does not respond to other agents such as tricyclicsagents such as tricyclics
  • 27. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Antidepressants: MAOIsAntidepressants: MAOIs Side EffectsSide Effects • Few side effects—orthostatic hypotensionFew side effects—orthostatic hypotension most commonmost common TachycardiaTachycardia PalpitationsPalpitations DizzinessDizziness DrowsinessDrowsiness InsomniaInsomnia HeadacheHeadache AnorexiaAnorexia NauseaNausea Blurred visionBlurred vision ImpotenceImpotence
  • 28. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Antidepressants: MAOIsAntidepressants: MAOIs OverdoseOverdose • Symptoms appear 12 hours after ingestionSymptoms appear 12 hours after ingestion • Tachycardia, circulatory collapse,Tachycardia, circulatory collapse, seizures, comaseizures, coma • Treatment: protect brain and heart,Treatment: protect brain and heart, eliminate toxineliminate toxin – Gastric lavageGastric lavage – Urine acidificationUrine acidification – HemodialysisHemodialysis
  • 29. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Antidepressants: MAOIsAntidepressants: MAOIs Hypertensive Crisis and TyramineHypertensive Crisis and Tyramine • Ingestion of foods and/or drinks withIngestion of foods and/or drinks with the amino acid TYRAMINE leads tothe amino acid TYRAMINE leads to hypertensive crisis, which may leadhypertensive crisis, which may lead to cerebral hemorrhage, stroke,to cerebral hemorrhage, stroke, coma, or deathcoma, or death
  • 30. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Antidepressants: MAOIsAntidepressants: MAOIs Hypertensive Crisis and TyramineHypertensive Crisis and Tyramine Avoid foods that contain tyramine!Avoid foods that contain tyramine! • Aged, mature cheeses (cheddar, blue, Swiss)Aged, mature cheeses (cheddar, blue, Swiss) • Smoked/pickled or aged meats, fish, poultrySmoked/pickled or aged meats, fish, poultry (herring, sausage, corned beef, salami, pepperoni,(herring, sausage, corned beef, salami, pepperoni, patĂ©)patĂ©) • Yeast extractsYeast extracts • Red wines (Chianti, burgundy, sherry, vermouth)Red wines (Chianti, burgundy, sherry, vermouth) • Italian broad beans (fava beans)Italian broad beans (fava beans)
  • 31. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Second-Generation AntidepressantsSecond-Generation Antidepressants • NewerNewer • Fewer side effects than tricyclics, but notFewer side effects than tricyclics, but not superior in overall efficacy or onset of actionsuperior in overall efficacy or onset of action – trazodone (Desyrel)trazodone (Desyrel) – bupropion (Wellbutrin, Zyban)bupropion (Wellbutrin, Zyban) – selective serotonin reuptake inhibitors (SSRIs)selective serotonin reuptake inhibitors (SSRIs)
  • 32. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Second-GenerationSecond-Generation Antidepressants and SSRIsAntidepressants and SSRIs Mechanism of ActionMechanism of Action • Selectively inhibit serotonin reuptakeSelectively inhibit serotonin reuptake • Little or no effect on norepinephrine orLittle or no effect on norepinephrine or dopamine reuptakedopamine reuptake • Results in increased serotoninResults in increased serotonin concentrations at nerve endingsconcentrations at nerve endings Advantage over tricyclics and MAOIs:Advantage over tricyclics and MAOIs: Little or no effect on cardiovascular systemLittle or no effect on cardiovascular system
  • 33. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Second-Generation AntidepressantsSecond-Generation Antidepressants Therapeutic UsesTherapeutic Uses • Used for depression—very few serious side effectsUsed for depression—very few serious side effects • Bipolar affective disorderBipolar affective disorder • ObesityObesity • Eating disordersEating disorders • Obsessive-compulsive disorderObsessive-compulsive disorder • Panic attacksPanic attacks • MyoclonusMyoclonus • Treatment of various substance abuse problemsTreatment of various substance abuse problems (bupropion [Zyban] is used for smoking cessation(bupropion [Zyban] is used for smoking cessation treatment)treatment)
  • 34. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Second-Generation AntidepressantsSecond-Generation Antidepressants Side EffectsSide Effects Body SystemBody System EffectsEffects CNSCNS Headache, dizziness,Headache, dizziness, tremor, nervousness,tremor, nervousness, insomnia, fatigueinsomnia, fatigue GIGI Nausea, diarrhea,Nausea, diarrhea, constipation, dry mouthconstipation, dry mouth OtherOther Sweating, sexualSweating, sexual dysfunctiondysfunction
  • 35. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Second-Generation AntidepressantsSecond-Generation Antidepressants Drug InteractionsDrug Interactions • Highly bound to plasma proteinsHighly bound to plasma proteins • Compete with other protein-binding drugs,Compete with other protein-binding drugs, resulting in more free, unbound drug toresulting in more free, unbound drug to cause a more pronounced drug effectcause a more pronounced drug effect
  • 36. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. AntipsychoticsAntipsychotics • Drugs used to treat serious mental illnessDrugs used to treat serious mental illness • Behavioral problems or psychotic disordersBehavioral problems or psychotic disorders
  • 37. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. AntipsychoticsAntipsychotics • Thioxanthenes: chlorprothixene, thiothixeneThioxanthenes: chlorprothixene, thiothixene (Navane)(Navane) • Butyrophenones: haloperidol (Haldol)Butyrophenones: haloperidol (Haldol) • Dihydroindolones: molindone (Moban)Dihydroindolones: molindone (Moban) • Dibenzoxazepine: loxapine (Loxitane)Dibenzoxazepine: loxapine (Loxitane) • Phenothiazines: three structural groupsPhenothiazines: three structural groups
  • 38. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. AntipsychoticsAntipsychotics Phenothiazine Structural GroupsPhenothiazine Structural Groups • Aliphatic: chlorpromazine (Thorazine),Aliphatic: chlorpromazine (Thorazine), triflupromazine (Vesprin)triflupromazine (Vesprin) • Piperidine: mesoridazine (Serentil),Piperidine: mesoridazine (Serentil), thioridazine (Mellaril)thioridazine (Mellaril) • Piperazine: fluphenazine (Prolixin),Piperazine: fluphenazine (Prolixin), perphenazine (Trilafon), prochlorperazineperphenazine (Trilafon), prochlorperazine (Compazine), trifluoperazine (Stelazine)(Compazine), trifluoperazine (Stelazine) Largest group of psychotropic agentsLargest group of psychotropic agents
  • 39. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. AntipsychoticsAntipsychotics Atypical AntipsychoticsAtypical Antipsychotics • clozapine (Clozaril)clozapine (Clozaril) • risperidone (Risperdal)risperidone (Risperdal) • olanzapine (Zyprexa)olanzapine (Zyprexa) • quetiapine (Seroquel)quetiapine (Seroquel)
  • 40. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Antipsychotics: Mechanism of ActionAntipsychotics: Mechanism of Action • Block dopamine receptors in the brainBlock dopamine receptors in the brain (limbic system, basal ganglia)—areas(limbic system, basal ganglia)—areas associated with emotion, cognitive function,associated with emotion, cognitive function, motor functionmotor function • Dopamine levels in the CNS are decreasedDopamine levels in the CNS are decreased • Result: tranquilizing effect in psychoticResult: tranquilizing effect in psychotic patientspatients
  • 41. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Antipsychotics: Mechanism of ActionAntipsychotics: Mechanism of Action • The newer, atypical antipsychotics also blockThe newer, atypical antipsychotics also block specific serotonin receptors (serotonin-2specific serotonin receptors (serotonin-2 [5HT2] receptors).[5HT2] receptors). • This is responsible for their improvedThis is responsible for their improved efficacy and safety profiles.efficacy and safety profiles.
  • 42. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Antipsychotics: Drug EffectsAntipsychotics: Drug Effects • Block dopamine receptors in CNSBlock dopamine receptors in CNS • Block alpha receptors (causing hypertension,Block alpha receptors (causing hypertension, other cardiovascular effects)other cardiovascular effects) • Block histamine receptors (causingBlock histamine receptors (causing anticholinergic effects)anticholinergic effects) • Block serotoninBlock serotonin • Also function as antiemeticsAlso function as antiemetics • Antianxiety effectsAntianxiety effects
  • 43. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Antipsychotics: Therapeutic UsesAntipsychotics: Therapeutic Uses • Treatment of serious mental illnesses:Treatment of serious mental illnesses: – Bipolar affective disorderBipolar affective disorder – Depressive and drug-induced psychosesDepressive and drug-induced psychoses – SchizophreniaSchizophrenia – AutismAutism • Movement disorders (such as Tourette’sMovement disorders (such as Tourette’s syndrome)syndrome) • Some medical conditionsSome medical conditions – Nausea, intractable hiccupsNausea, intractable hiccups
  • 44. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Antipsychotics: Side EffectsAntipsychotics: Side Effects Body SystemBody System EffectsEffects CNSCNS Sedation, deliriumSedation, delirium CardiovascularCardiovascular Orthostatic hypotension,Orthostatic hypotension, syncope, dizziness,syncope, dizziness, ECG changesECG changes DermatologicDermatologic Photosensitivity, skin rash,Photosensitivity, skin rash, hyperpigmentation, pruritushyperpigmentation, pruritus
  • 45. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Antipsychotics: Side EffectsAntipsychotics: Side Effects Body SystemBody System EffectsEffects GIGI Dry mouth, constipationDry mouth, constipation GUGU Urinary hesitancy orUrinary hesitancy or retention, impaired erectionretention, impaired erection HematologicHematologic Leukopenia andLeukopenia and agranulocytosisagranulocytosis Metabolic/endocrineMetabolic/endocrine Galactorrhea, irregularGalactorrhea, irregular mensesmenses increased appetite,increased appetite, polydipsiapolydipsia
  • 46. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Psychotherapeutic Agents:Psychotherapeutic Agents: Nursing ImplicationsNursing Implications • Before beginning therapy, assess both theBefore beginning therapy, assess both the physical and emotional status of patientsphysical and emotional status of patients • Obtain baseline VS, including postural BPObtain baseline VS, including postural BP readingsreadings • Obtain liver and renal function tests (andObtain liver and renal function tests (and baseline platelet levels for MAOIs)baseline platelet levels for MAOIs)
  • 47. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Psychotherapeutic Agents:Psychotherapeutic Agents: Nursing ImplicationsNursing Implications • Assess for possible contraindications toAssess for possible contraindications to therapy, cautious use, and potential drugtherapy, cautious use, and potential drug interactionsinteractions • Assess LOC, mental alertness, potentialAssess LOC, mental alertness, potential for injury to self and othersfor injury to self and others • Check the patient’s mouth to make sureCheck the patient’s mouth to make sure oral doses are swallowedoral doses are swallowed
  • 48. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Psychotherapeutic Agents:Psychotherapeutic Agents: Nursing ImplicationsNursing Implications • Provide simple explanations about the drug,Provide simple explanations about the drug, its effects, and the length of time beforeits effects, and the length of time before therapeutic effects can be expectedtherapeutic effects can be expected • Abrupt withdrawal should be avoidedAbrupt withdrawal should be avoided • Advise patients to change positions slowlyAdvise patients to change positions slowly to avoid postural hypotension and possibleto avoid postural hypotension and possible injuryinjury
  • 49. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Psychotherapeutic Agents:Psychotherapeutic Agents: Nursing ImplicationsNursing Implications • The combination of drug therapy andThe combination of drug therapy and psychotherapy is emphasized becausepsychotherapy is emphasized because patients need to learn and acquire morepatients need to learn and acquire more effective coping skillseffective coping skills • Only small amounts of medications shouldOnly small amounts of medications should be dispensed at a time to minimize the riskbe dispensed at a time to minimize the risk of suicide attemptsof suicide attempts • Simultaneous use of these agents withSimultaneous use of these agents with alcohol or other CNS depressants canalcohol or other CNS depressants can be fatalbe fatal
  • 50. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Psychotherapeutic Agents:Psychotherapeutic Agents: Nursing ImplicationsNursing Implications AntidepressantsAntidepressants • Many cautions, contraindications, and interactionsMany cautions, contraindications, and interactions exist pertaining to the use of antidepressants.exist pertaining to the use of antidepressants. • Inform patients that it may take 1 to 3, even 4,Inform patients that it may take 1 to 3, even 4, weeks to see therapeutic effects.weeks to see therapeutic effects. • Monitor patients closely during this time andMonitor patients closely during this time and provide support.provide support.
  • 51. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Psychotherapeutic Agents:Psychotherapeutic Agents: Nursing ImplicationsNursing Implications AntidepressantsAntidepressants • Sedation often occurs with tricyclic therapy; notifySedation often occurs with tricyclic therapy; notify physician if this lasts more than 2 weeks.physician if this lasts more than 2 weeks. • Assist elderly or weakened patients with ambulationAssist elderly or weakened patients with ambulation and other activities as falls may occur due toand other activities as falls may occur due to drowsiness or postural hypotension.drowsiness or postural hypotension.
  • 52. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Psychotherapeutic Agents:Psychotherapeutic Agents: Nursing ImplicationsNursing Implications AntidepressantsAntidepressants • Tricyclics may need to be weaned and discontinuedTricyclics may need to be weaned and discontinued before undergoing surgery to avoid interactions withbefore undergoing surgery to avoid interactions with anesthetic agents.anesthetic agents. • Monitor for side effects and discuss with patients.Monitor for side effects and discuss with patients. • Encourage patients to wear medication ID badgesEncourage patients to wear medication ID badges naming the agent being taken.naming the agent being taken.
  • 53. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Psychotherapeutic Agents:Psychotherapeutic Agents: Nursing ImplicationsNursing Implications AntidepressantsAntidepressants • Caffeine and cigarette smoking may decreaseCaffeine and cigarette smoking may decrease effectiveness of medication therapyeffectiveness of medication therapy • Instruct patients and family regarding tyramine-Instruct patients and family regarding tyramine- containing foods and signs and symptoms ofcontaining foods and signs and symptoms of hypertensive crisishypertensive crisis
  • 54. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Psychotherapeutic Agents:Psychotherapeutic Agents: Nursing ImplicationsNursing Implications Antipsychotics—PhenothiazinesAntipsychotics—Phenothiazines • Instruct patients to wear sunscreen due toInstruct patients to wear sunscreen due to photosensitivityphotosensitivity • Avoid taking antacids or antidiarrheal preparationsAvoid taking antacids or antidiarrheal preparations within 1 hour of a dosewithin 1 hour of a dose • Do not take alcohol or other CNS depressantsDo not take alcohol or other CNS depressants with these medicationswith these medications
  • 55. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Psychotherapeutic Agents:Psychotherapeutic Agents: Nursing ImplicationsNursing Implications Antipsychotics—PhenothiazinesAntipsychotics—Phenothiazines • Long-term haloperidol therapy may result in tremors,Long-term haloperidol therapy may result in tremors, nausea, vomiting, or uncontrollable shaking of smallnausea, vomiting, or uncontrollable shaking of small muscle groups; these symptoms should be reportedmuscle groups; these symptoms should be reported to the physicianto the physician • Oral forms may be taken with meals to decreaseOral forms may be taken with meals to decrease GI upsetGI upset • These agents may cause drowsiness, dizziness, orThese agents may cause drowsiness, dizziness, or fainting; instruct patients to change positions slowlyfainting; instruct patients to change positions slowly
  • 56. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Psychotherapeutic Agents:Psychotherapeutic Agents: Nursing ImplicationsNursing Implications Monitor for therapeutic effects:Monitor for therapeutic effects: • Monitor mental alertness, cognition, affect,Monitor mental alertness, cognition, affect, mood,ability to carry out activities of dailymood,ability to carry out activities of daily living, appetite, and sleep patternsliving, appetite, and sleep patterns • Monitor the patient’s potential for self-injuryMonitor the patient’s potential for self-injury during the delay between the start of therapyduring the delay between the start of therapy and symptomatic improvementand symptomatic improvement
  • 57. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Psychotherapeutic Agents:Psychotherapeutic Agents: Nursing ImplicationsNursing Implications Monitor for therapeutic effectsMonitor for therapeutic effects • For antidepressants:For antidepressants: – Improved sleep patterns and nutrition, increasedImproved sleep patterns and nutrition, increased feelings of self-esteem, decreased feeling offeelings of self-esteem, decreased feeling of hopelessness, increased interest in self andhopelessness, increased interest in self and appearance, increased interest in daily activities,appearance, increased interest in daily activities, fewer depressive manifestations or suicidalfewer depressive manifestations or suicidal thoughts or ideationsthoughts or ideations
  • 58. Copyright © 2002, 1998, Elsevier Science (USA). All rights reserved. Psychotherapeutic Agents:Psychotherapeutic Agents: Nursing ImplicationsNursing Implications Monitor for therapeutic effectsMonitor for therapeutic effects • For antipsychotics:For antipsychotics: – Improved mood and affect, alleviation ofImproved mood and affect, alleviation of psychotic symptoms and episodespsychotic symptoms and episodes – Decrease in hallucinations, paranoia, delusions,Decrease in hallucinations, paranoia, delusions, garbled speech, inability to copegarbled speech, inability to cope